N-Acetyl Selank 10mg

N-Acetyl Selank 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

N-Acetyl Selank is a modified synthetic peptide research compound developed for advanced laboratory investigations involving peptide biology, intracellular signalling and molecular regulatory pathways. The N-acetyl modification distinguishes this compound from the unmodified Selank peptide and makes it of particular interest in comparative peptide chemistry and controlled molecular research. This preparation contains 10 mg of lyophilized N-Acetyl Selank supplied in a sealed research vial. Independent analytical testing confirmed an assay content of 10.01 mg for this production batch. Chromatographic analysis confirmed 99.1 percent purity, while identity was independently evaluated through spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.010 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its defined molecular identity, reproducible analytical profile and comprehensive third-party verification, N-Acetyl Selank provides researchers with a well-characterised peptide material suitable for advanced peptide investigations and controlled in vitro laboratory studies.  

Peptide Overview

N-Acetyl Selank is a modified peptide research compound commonly utilised in laboratory investigations involving peptide chemistry, molecular interactions and intracellular communication. N-acetylation represents a structural modification of the peptide, providing researchers with an additional molecular characteristic for comparative investigations involving modified and unmodified peptide structures. Researchers may employ N-Acetyl Selank in controlled experimental models designed to investigate peptide-mediated signalling pathways, molecular interactions and biochemical regulatory systems. Its defined molecular structure and measurable analytical characteristics allow identity and quality parameters to be evaluated using complementary chromatographic and mass spectrometric techniques. Today, N-Acetyl Selank forms part of the expanding field of modified peptide compounds investigated within experimental peptide science and molecular research.  

Historical Background and Scientific Context

Advances in peptide engineering have enabled researchers to investigate structural modifications designed to alter or study the physicochemical characteristics of peptide molecules. N-terminal acetylation is one such modification and is frequently examined within peptide chemistry as researchers investigate differences between modified and corresponding unmodified peptide structures. Modern analytical technologies including ultra-high-performance liquid chromatography, spectrum-based identification and mass spectrometry have significantly improved the ability to characterise modified peptides and verify their analytical identity. These methods can be combined with microbiological analysis, bacterial endotoxin testing and elemental impurity screening to provide broader batch-specific analytical documentation. N-Acetyl Selank represents a modified peptide research compound suitable for controlled laboratory investigations involving peptide chemistry and molecular biology.  

Mechanistic Focus in Research

Within controlled laboratory environments, N-Acetyl Selank may be investigated in relation to peptide signalling, molecular interactions and intracellular communication systems. Research investigations frequently explore:

• Modified peptide chemistry
• Peptide-mediated signalling pathways
• Intracellular molecular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Comparative modified-peptide investigations
• Molecular interaction studies
• Controlled in vitro peptide research

These experimental models allow researchers to investigate peptide-related molecular mechanisms under carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of N-Acetyl Selank supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric and microbiological analytical techniques. Batch: GF-NSEL10-B243

• Assay Content: 10.01 mg
• Purity: 99.1 %
• Identification by Spectrum: 954
• Identification by Retention Time: 0.983
• Molecular Ion Mass Identification: 793 Da
• Bacterial Endotoxins: 0.010 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 10.01 mg with a reported analytical uncertainty of ±0.05 mg. Purity analysis confirmed 99.1 percent purity with a reported analytical uncertainty of ±0.5 percent. Identity was evaluated through spectrum analysis with a reported result of 954 and retention time analysis with a result of 0.983. Mass spectrometry identified a molecular ion mass of 793 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result of 0.010 EU/mg, remaining within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent confirmation of important identity, purity, microbiological and batch-specific quality parameters for the tested N-Acetyl Selank research material.  

Research Applications

Within controlled laboratory environments, N-Acetyl Selank may be utilised in experimental models designed to investigate peptide biology, molecular signalling and biochemical regulatory mechanisms. Examples of research applications include:

• Modified peptide chemistry investigations
• Peptide signalling research
• Intracellular signalling investigations
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Molecular interaction research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. Each production batch undergoes extensive testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• Spectrum-based identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation. Our analytical verification programme includes assay determination, purity confirmation, spectrum-based identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing. Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability and independent analytical verification of the tested research compound.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.1 % purity confirmed by COA
• Assay content verified at 10.01 mg
• Identification confirmed by spectrum and retention time analysis
• Molecular ion mass identified at 793 Da
• Bacterial endotoxin level of 0.010 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.